Vanda Pharmaceuticals | VNDA - Ordinary Share Capital


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Vanda Pharmaceuticals

Vanda Pharmaceuticals reported $57K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.


Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Agios Pharmaceuticals AGIO:US USD 72K 1000
Akebia Therapeutics AKBA:US USD 2K 0
Alnylam Pharmaceuticals ALNY:US USD 1.24M 3K
Anika Therapeutics ANIK:US USD 147K 1000
Arrowhead Research ARWR:US USD 199K 0
AstraZeneca AZN:LN USD 387M 0
Bluebird Bio BLUE:US USD 1.06M 234K
Eli Lilly LLY:US USD 593.5M 600K
Esperion Therapeutics ESPR:US USD 87K 12K
Halozyme Therapeutics HALO:US USD 132K 3K
Heron Therapeutics HRTX:US USD 1.19M 2K
Insmed INSM:US USD 1.36M 7K
Intercept Pharmaceuticals ICPT:US USD 42K 0
J&J JNJ:US USD 3.12B 0
Minerva Neurosciences NERV:US USD 1000 0
Moderna Inc MRNA:US USD 38.4K 100
Novartis NVS:US USD 842M 48M
PTC Therapeutics PTCT:US USD 73K 1000
Puma Biotechnology PBYI:US USD 5K 0
Sangamo BioSciences SGMO:US USD 1.72M 50K
Takeda 4502:JP JPY 1.68T 11M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 57M 0
Ultragenyx Pharmaceutical RARE:US USD 71K 1000
Vanda Pharmaceuticals VNDA:US USD 57K 0
Veracyte VCYT:US USD 72K 0